Log In
Print
BCIQ
Print
Print this Print this
 

CicloMulsion

  Manage Alerts
Collapse Summary General Information
Company NeuroVive Pharmaceutical AB
DescriptionCremophor-free IV cyclosporine formulation
Molecular Target
Mechanism of Action 
Therapeutic ModalityMacrocycle
Latest Stage of DevelopmentPhase II
Standard IndicationRenal damage
Indication DetailsPrevent acute kidney injury (AKI) following major cardiac surgery
Regulatory Designation
Partner Sanofi

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

2

$7.5M

0

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone
Get a free BioCentury trial today